CYRX · Cryoport, Inc.
$14.93
-0.24 (-1.58%)
At close · Jul 29
Market Cap
$764.60M
Shares
50.40M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$176.18M
-22.9%
FY2025
Net Income
$78.3M
+168.2%
FY2025
Gross Margin
47.14%
+3.5pp
FY2025
Operating Margin
-20.89%
+36.4pp
FY2025
Diluted EPS
$1.40
+156.2%
FY2025
Operating Cash Flow
-$8.58M
+47.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $192M – $196M | $182.94M | $176.18MG | $228.39MG | $233.26M | $237.28M | $222.61M | $33.94M | $19.63M | $11.95M | $5.88M | $3.94M | $2.66M | $1.1M | $555.64K | |
| — | $96.61M | $93.12M | $128.75M | $133.92M | $133.4M | $126.03M | $16.59M | $9.39M | $5.99M | $3.99M | $2.77M | $2.22M | $1.59M | $1.39M | |
| — | $86.33M | $83.05M | $99.63M | $99.33M | $103.87M | $96.58M | $17.35M | $10.24M | $5.97M | $1.89M | $1.17M | $436.96K | -$487.28K | -$836.82K | |
| — | — | 47.14% | 43.62% | 42.59% | 43.78% | 43.38% | 51.12% | 52.18% | 49.91% | 32.14% | 29.7% | 16.43% | -44.28% | -150.61% | |
| — | $17.01M | $17.04M | $17.71M | $18.04M | $15.72M | $16.84M | $3.74M | $1.84M | $1.21M | $550.26K | $352.58K | $409.11K | $425.45K | $491.85K | |
| — | $12.66M | — | — | — | — | — | $13.82M | $7.25M | $5.23M | $4.16M | — | — | — | — | |
| — | $22.69M | — | — | — | — | — | $17.47M | $9.8M | $7.42M | $5.93M | — | — | — | — | |
| — | $108.54M | $102.82M | $148.98M | $146.88M | $120.06M | $97.56M | — | — | — | — | $6.41M | $5.11M | $5.41M | $6.11M | |
| — | $12.7M | $12.7M | $17M | $16.3M | $15.1M | $14.4M | $313.3K | $0 | $0 | $30.1K | $43.2K | $92.2K | $112.26K | — | |
| — | — | $27.71M | $30.76M | $27.49M | $22.77M | $20.25M | $2.42M | $857.94K | $664.83K | $239.23K | $197.94K | $311.59K | $393.96K | $343.03K | |
| — | $125.55M | $119.86M | $230.5M | $214.49M | $135.78M | $114.41M | $35.03M | $18.88M | $13.86M | $10.63M | $6.76M | $5.52M | $5.84M | $6.6M | |
| — | -$39.23M | -$36.81M | -$130.87M | -$115.16M | -$31.9M | -$17.83M | -$17.68M | -$8.64M | -$7.89M | -$8.74M | -$5.59M | -$5.08M | -$6.32M | -$7.43M | |
| — | — | -20.89% | -57.3% | -49.37% | -13.45% | -8.01% | -52.07% | -44.05% | -66.02% | -148.6% | -142.12% | -190.92% | -574.67% | -1338.05% | |
| — | — | -$9.09M | -$100.11M | -$87.67M | -$9.14M | $2.42M | -$15.26M | -$7.79M | -$7.23M | -$8.5M | -$5.4M | -$4.77M | -$5.93M | -$7.09M | |
| — | $2.21M | $2.36M | $4.11M | $5.5M | $6.14M | $4.69M | $1.37M | $69.25K | $15.69K | $1.07M | $1.43M | $784.45K | $72.86K | $527.75K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $11.94K | |
| — | $4.24M | $4.64M | $17.39M | $15.81M | -$3.19M | -$256.01M | -$594.86K | -$891.03K | -$1356 | -$9901 | -$4266 | -$8078 | -$56.38K | -$396.65K | |
| — | -$34.99M | -$32.17M | -$113.48M | -$99.35M | -$35.09M | -$273.84M | -$18.27M | -$9.54M | -$7.89M | -$9.82M | -$7.03M | -$19.56M | -$6.38M | -$7.83M | |
| — | $1.67M | $1.8M | $1.28M | $239K | $2.24M | $1.69M | $61.58K | $19.95K | $5143 | $3625 | $1600 | $1600 | $1600 | $1600 | |
| — | $79.74M | $78.3M | -$114.76M | -$99.59M | -$37.33M | -$275.53M | -$18.33M | -$9.56M | -$7.9M | -$9.82M | -$7.03M | -$19.57M | -$6.38M | -$7.83M | |
| — | — | 44.44% | -50.25% | -42.69% | -15.73% | -123.77% | -54.01% | -48.69% | -66.08% | -166.95% | -178.56% | -735.56% | -579.94% | -1409.72% | |
| — | $71.74M | $70.3M | -$122.76M | -$107.59M | -$45.33M | -$283.72M | — | — | -$7.9M | -$15.06M | -$12.2M | -$19.57M | — | — | |
| — | $92.26M | $95.75M | -$109.62M | -$91.1M | -$70.64M | -$282.15M | -$18.38M | -$9.55M | — | — | — | — | — | — | |
| USD/shares | — | — | $1.40 | -$2.49 | -$2.21 | -$0.93 | -$6.18 | — | — | — | — | — | — | -$0.05 | — |
| USD/shares | — | — | $1.40 | -$2.49 | -$2.21 | -$0.93 | -$6.19 | — | — | — | — | — | — | — | — |
| shares | — | — | 50.07M | 49.35M | 48.74M | 48.99M | 45.93M | 33.39M | 28.21M | 22.96M | 7.34M | 5.01M | 48.85M | 37.76M | 28.97M |
| shares | — | — | 50.07M | 49.35M | 48.74M | 48.99M | 45.93M | 33.39M | 28.21M | 22.96M | 7.34M | 5.01M | 48.85M | 38.17M | 28.97M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2025: $123.89M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
10.61×
Peer median 25.79×
Peer medians compare against the 8 similar-size Integrated Freight & Logistics companies (of 25 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Life Sciences Services | $101,028,000 | $85,335,000 | $81,188,000 | — | — | — | — |
| Life Sciences Products | $75,149,000 | $71,434,000 | $87,474,000 | — | — | — | — |
| Global Logistics Solutions | — | — | — | — | $222,608,000 | $78,696,000 | $33,942,000 |
| Life Science Supply Chain Solutions Segment | — | $156,951,000 | $145,781,000 | $135,179,000 | — | — | — |
| Life Science Systems Segment | — | $71,434,000 | $87,474,000 | $102,098,000 | — | — | — |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Americas | $131,260,000 | $113,545,000 | $117,895,000 | $128,209,000 | $120,270,000 | $49,555,000 | $28,801,000 |
| EMEA | $25,134,000 | $27,022,000 | $27,650,000 | $66,913,000 | $59,334,000 | $20,316,000 | $4,523,000 |
| Asia Pacific | $19,783,000 | $16,202,000 | $23,117,000 | $42,155,000 | $43,004,000 | $8,825,000 | $618,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Service | $96,497,000 | $82,044,000 | $79,494,000 | $133,879,000 | — | $55,299,000 | $33,942,000 |
| Product | $79,680,000 | $74,725,000 | $89,168,000 | $103,398,000 | — | $23,397,000 | — |
| Biologistics Solutions | $78,137,000 | $67,019,000 | $65,905,000 | $124,798,000 | — | — | — |
| Biostorage Bioservices | $18,360,000 | $15,025,000 | $13,589,000 | $9,081,000 | — | — | — |
| Animal Health | — | — | $30,379,000 | $33,465,000 | $33,353,000 | — | — |
| Biopharmaceutical | — | — | $192,583,000 | $193,879,000 | $180,203,000 | — | — |
| Reproductive Medicine | — | — | $10,293,000 | $9,933,000 | $9,052,000 | — | — |
Key facts
CIK
1124524
CUSIP
229050307
13F (30d)
29 filings
29 filers
Visit website
Investor relations